792 followers
Icotinib versus Cisplatin Plus Docetaxel as Adjuvant Chemotherapy in Patients with Stage II (N1+) Non-Small Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study https://t.co/BtGVzrxc3F
Icotinib versus Cisplatin Plus Docetaxel as Adjuvant Chemotherapy in Patients with Stage II (N1+) Non-Small Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study https://t.co/BtGVzrxc3F
Un piccolo studio cinese conferma -anche per l'ICOTINIB (https://t.co/LMCUS2MltU...)- la superiorità dello stesso alla normale chemioterapia adiuvante post-intervento nei tumori EGFR- mutati... https://t.co/JgZKr0vpmP